The Biology of TRIM37: Why It Matters

Every part of the human body is built using a set of instructions called genes. For a child with Mulibrey nanism, those instructions have a specific typo in a gene called TRIM37 ^[1][2]. Understanding this “typo” doesn’t change who your child is, but it explains why their body grows and develops in its own unique way.

The TRIM37 Gene: The Cellular Manager

To understand Mulibrey nanism, it helps to think of the TRIM37 gene as a “project manager” for your child’s cells. This gene provides instructions for making a protein that keeps the internal workspace of a cell organized and efficient ^[2][3].

When the TRIM37 protein is missing or doesn’t work correctly (known as a loss-of-function variant), several key “departments” in the cell struggle:

• The Centrosome (The Builder): This structure helps cells divide properly. Without TRIM37, cells can make mistakes during division, leading to errors in how the body’s tissues are constructed ^[4][5].
• The Peroxisome (The Recycler): These are small units that break down fats and detoxify the cell. TRIM37 helps ensure these “recycling centers” function correctly ^[6][7].
• The Growth Signal (mTORC1): TRIM37 is involved in a pathway that tells the cell when it is time to grow. When this signal is weak, it contributes to the severe growth failure (nanism) seen in the condition ^[7][8].

What “Autosomal Recessive” Means

Mulibrey nanism is an autosomal recessive condition. This is a common way for rare genetic traits to be passed down through families ^[9][10].

• Autosomal: The gene is located on one of the numbered chromosomes (specifically chromosome 17), meaning it affects boys and girls equally ^[10].
• Recessive: Everyone has two copies of the TRIM37 gene—one from their mother and one from their father. In an autosomal recessive condition, a child only develops the condition if both copies have a mutation ^[1][2].

Usually, parents are “carriers,” meaning they have one working copy and one mutated copy. Carriers typically have no symptoms because their one working gene is enough to do the job. When two carriers have a child, there is a 25% (1 in 4) chance the child will inherit the mutated gene from both parents ^[9].

How the Diagnosis is Confirmed

While doctors might suspect Mulibrey nanism based on a child’s growth or heart health, a definitive diagnosis requires genetic testing ^[11][1].

The gold standard for diagnosis is Whole-Exome Sequencing (WES). This test “reads” the coding sections of all 20,000+ genes in the body to look for mutations in TRIM37 ^[1][12]. Sometimes, doctors use “Trio-WES,” which tests the child and both parents at the same time to confirm the inheritance pattern ^[3][1].

Genetic Report Completeness Checklist

When you receive your child’s genetic report, it should contain several specific pieces of information to be considered complete:

• [ ] Gene Name: Explicitly lists TRIM37 ^[1].
• [ ] Zygosity / Variant Type: Identifies two mutations (e.g., “homozygous” if they are the same, or “compound heterozygous” if they are different), confirming that the mutations affect both copies of the gene ^[1][3].
• [ ] Classification: The variants should be labeled as Pathogenic (disease-causing) or Likely Pathogenic ^[3].
• [ ] Segregation: Notes whether the mutations were confirmed to be inherited from the parents ^[1][13].

If your report shows a Variant of Uncertain Significance (VUS), it means a change was found, but scientists aren’t yet sure if it causes the condition. In these cases, you should seek follow-up with a clinical geneticist. Further familial testing (like segregation analysis) is often needed to formally reclassify the variant, and clinical symptoms remain the most important factor in diagnosis ^[3].